Jesse L. Yedinak

Jesse L. Yedinak

Auto-generated profile, based on publicly available information

Jesse L. Yedinak

Department of Epidemiology, Brown University School of Public Health, 121 South Main Street, Box G-S-121-2, Providence, RI, 02912, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 January 2019 in Harm Reduction Journal
Verified
Journal Article
Open access
PDF file
JGJacqueline E. Goldman
Jacqueline E. Goldman
KWKatherine M. Waye
Katherine M. Waye
KPKobe A. Periera
Kobe A. Periera
MKMaxwell S. Krieger
Maxwell S. Krieger
JYJesse L. Yedinak
Jesse L. Yedinak
BMBrandon David Lewis Marshall
Brandon David Lewis Marshall
In 2016, drug overdose deaths exceeded 64,000 in the United States, driven by a sixfold increase in deaths attributable to illicitly manufactured fentanyl. Rapid fentanyl test strips (FTS), used to detect fentanyl in illicit drugs, may help inform people who use drugs about their risk of fentanyl exposure prior to consumption. This qualitative study assessed perceptions of FTS among young adults. From May to September 2017, we recruited a convenience sample of 93 young adults in Rhode Island (age 18–35 years) with self-reported drug use in the past 30 days to participate in a pilot study aimed at better understanding perspectives of using take-home FTS for personal use. Participants completed a baseline quantitative survey, then completed a training to learn how to use the FTS. Participants then received ten FTS for personal use and were asked to return 2–4 weeks later to complete a brief quantitative and structured qualitative interview. Interviews were transcribed, coded, and double coded in NVivo (Version 11). Of the 81 (87%) participants who returned for follow-up, the majority (n = 62, 77%) used at least one FTS, and of those, a majority found them to be useful and straightforward to use. Positive FTS results led some participants to alter their drug use behaviors, including discarding their drug supply, using with someone else, and keeping naloxone nearby. Participants also reported giving FTS to friends who they felt were at high risk for fentanyl exposure. These findings provide important perspectives on the use of FTS among young adults who use drugs. Given the high level of acceptability and behavioral changes reported by study participants, FTS may be a useful harm reduction intervention to reduce fentanyl overdose risk among this population. The study protocol is registered with the US National Library of Medicine, Identifier NCT03373825, 12/24/2017, registered retrospectively. https://clinicaltrials.gov/ct2/show/NCT03373825?id=NCT03373825&rank=1

8 February 2018 in Harm Reduction Journal
Verified
Journal Article
Open access
PDF file
MKMaxwell S. Krieger
Maxwell S. Krieger
JYJesse L. Yedinak
Jesse L. Yedinak
JBJane A. Buxton
Jane A. Buxton
MLMark Lysyshyn
Mark Lysyshyn
EBEdward Bernstein
Edward Bernstein
BMBrandon David Lewis Marshall
Brandon David Lewis Marshall
Synthetic opioid overdose mortality among young adults has risen more than 300% in the USA since 2013, primarily due to the contamination of heroin and other drugs with illicitly manufactured fentanyl. Rapid test strips, which can be used to detect the presence of fentanyl in drug samples (before use) or urine (after use), may help inform people about their exposure risk. The purpose of this study was to determine whether young adults who use drugs were willing to use rapid test strips as a harm reduction intervention to prevent overdose. We hypothesized that those who had ever overdosed would be more willing to use the test strips. We recruited a convenience sample of young adults who use drugs in Rhode Island from May to September 2017. Eligible participants (aged 18 to 35 with past 30-day drug use) completed an interviewer-administered survey. The survey assessed participant’s socio-demographic and behavioral characteristics, overdose risk, as well as suspected fentanyl exposure, and willingness to use take-home rapid test strips to detect fentanyl contamination in drugs or urine. Participants were then trained to use the test strips and were given ten to take home. Among 93 eligible participants, the mean age was 27 years (SD = 4.8), 56% (n = 52) of participants were male, and 56% (n = 52) were white. Over one third (n = 34, 37%) had a prior overdose. The vast majority (n = 86, 92%) of participants wanted to know if there was fentanyl in their drug supply prior to their use. Sixty-five (70%) participants reported concern that their drugs were contaminated with fentanyl. After the brief training, nearly all participants (n = 88, 95%) reported that they planned to use the test strips. More than 90% of participants reported willingness to use rapid test strips regardless of having ever overdosed, suggesting that rapid fentanyl testing is an acceptable harm reduction intervention among young people who use drugs in Rhode Island. Study follow-up is ongoing to determine whether, how, and under what circumstances participants used the rapid test strips and if a positive result contributed to changes in overdose risk behavior.

1 February 2019 in Addictive Behaviors
Verified
Journal Article
Closed access
KWKatherine M. Waye
Katherine M. Waye
JGJonathan Goyer
Jonathan Goyer
DDDebra Dettor
Debra Dettor
LMLinda Mahoney
Linda Mahoney
ESElizabeth A. Samuels
Elizabeth A. Samuels
BMBrandon David Lewis Marshall
Brandon David Lewis Marshall

1 August 2017 in International Journal of Drug Policy
Verified
Journal Article
Closed access
BMBrandon David Lewis Marshall
Brandon David Lewis Marshall
MKMaxwell S. Krieger
Maxwell S. Krieger
JYJesse L. Yedinak
Jesse L. Yedinak
POPatricia Ogera
Patricia Ogera
PBPriya Banerjee
Priya Banerjee
TGTraci C. Green
Traci C. Green

1 May 2016 in International Journal of Drug Policy
Verified
Journal Article
Closed access
BMBrandon David Lewis Marshall
Brandon David Lewis Marshall
TGTraci C. Green
Traci C. Green
JYJesse L. Yedinak
Jesse L. Yedinak
SHScott E. Hadland
Scott E. Hadland

29 November 2016 in Substance Abuse Treatment, Prevention, and Policy
Verified
Journal Article
Open access
PDF file
ELElliott J. Liebling
Elliott J. Liebling
JYJesse L. Yedinak
Jesse L. Yedinak
TGTraci C. Green
Traci C. Green
SHScott E. Hadland
Scott E. Hadland
MCMelissa A. Clark
Melissa A. Clark
BMBrandon David Lewis Marshall
Brandon David Lewis Marshall
Non-medical prescription opioid (NMPO) use is a substantial public health problem in the United States, with 1.5 million new initiates annually. Only 746,000 people received treatment for NMPO use in 2013, demonstrating substantial disparities in access to treatment. This study aimed to assess correlates of accessing substance use treatment among young adult NMPO users in Rhode Island, a state heavily impacted by NMPO use and opioid overdose. This analysis uses data from a study of 200 Rhode Island residents aged 18 to 29 who reported NMPO use in the past 30 days. We compared individuals who had ever successfully enrolled in a substance use treatment program without ever facing barriers, individuals who had ever attempted to enroll but were unable, and individuals who never attempted to enroll. We used multinomial logistic regression to determine the independent correlates of never attempting and unsuccessfully attempting to access substance use treatment. Among 200 participants, the mean age was 24.5, 65.5% were male, and 61.5% were white. Nearly half (45.5%) had never attempted to enroll in substance use treatment, while 35.0% had successfully enrolled without ever facing barriers and 19.5% were unsuccessful in at least one attempt to enroll. In multivariable models, non-white participants were more likely to never have attempted to enroll compared to white participants. Previous incarceration, experiencing drug-related discrimination by the medical community, and a monthly income of $501 - $1500 were associated with a decreased likelihood of never attempting to enroll. A history of overdose and a monthly income of $501 - $1500 were associated with an increased likelihood of unsuccessfully accessing treatment. The most commonly reported barriers to accessing treatment were waiting lists (n = 23), health insurance not approving enrollment (n = 20), and inability to pay (n = 16). This study demonstrates significant disparities in access to treatment among young adults who report NMPO use. A history of overdose was shown to correlate with experiencing barriers to substance use treatment utilization. Interventions are needed to reduce drug-related discrimination in clinical settings and to provide mechanisms that link young adults (particularly with a history of overdose) to evidence-based treatment.